ArticleJournal of oncology2022

Development of a Clinically Oriented Model to Predict Antitumor Effects after PD-1/PD-L1 Inhibitor Therapy.

Xueping Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.